Adding single doses of tenofovir and emtricitabine to the standard single dose niverapine to treat HIV-infected women during labor reduces resistance to non-nucleoside reverse transcriptase inhibitor drugs, a new study found. By reducing the maternal niverapine resistance, it becomes possible to treat HIV-infected babies with commonly used medications.

Full Story:
France 24

Related Summaries